Hiroki Ozawa: New Guideline Updates on Pregnancy in Rheumatic Diseases
Hiroki Ozawa, Medical Doctor at St. Luke’s International Hospital, shared a post on LinkedIn:
“JCR 2026 Conference Report — Part 3 (Final): Pregnancy in RMD
Day 3 at JCR 2026 in Fukuoka brought an outstanding session on pregnancy complicated by rheumatic diseases. Here are the highlights.
Pregnancy in Rheumatic Diseases – Guideline Updates
This year saw the simultaneous revision of two Japanese clinical practice guidelines: one for anti-SS-A antibody-positive pregnancies and one for pregnancies complicated by antiphospholipid syndrome (APS). Naturally, the session was packed.
The session was chaired by Dr. Yokokawa, who has been doing critically important work – leading an investigator-initiated clinical trial on the use of hydroxychloroquine (HCQ) for the prevention of recurrent congenital heart block (CHB) in anti-SS-A antibody-positive pregnancies with a history of CHB in a prior child, and advocating for the expansion of HCQ’s approved indications to cover this use. CHB, though rare (approximately 1% of anti-SS-A-positive pregnancies), is irreversible and can be life-threatening, making prevention a top priority.
My colleagues Prof. Kishimoto, Dr. Kitada, and Dr. Nakai were also involved in the development of these guidelines – congratulations to them on this tremendous effort!
The anti-SS-A antibody-positive pregnancy guideline is structured around clinical questions (CQs) that follow the actual workflow of clinical care – from preconception assessment through postpartum follow-up of mother and child. This makes it highly practical and applicable at the bedside, bridging rheumatology, obstetrics, and pediatrics.
The APS pregnancy guideline is equally noteworthy for its inclusion of guidance on non-criteria APS – patients who are aPL-positive with pregnancy complications but do not fully meet formal classification criteria. This ensures that women who need treatment are not overlooked, reflecting a patient-centered approach to guideline development.
I look forward to the formal publication of both guidelines and to receiving feedback from colleagues around the world.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 15, 2026, 12:21Zara Grigoryan: Open Expert Dialogue to Shape Women’s Health in Armenia
-
Jun 15, 2026, 12:12Abhishek Saxena։ Can a 5PN Embryo Develop Normally?
-
Jun 15, 2026, 12:02Does Growth Hormone Help in IVF? – Fertility Plus
-
Jun 15, 2026, 11:55Allen Morgan: PRP in Fertility Treatment, Emerging Evidence and Future Directions
-
Jun 15, 2026, 11:49Hereditary Gynecologic Cancer Care Is Evolving, but Access and Health Systems Remain Unequal – IJGO
-
Jun 15, 2026, 11:41Celebrating Community and Support at the Annual Fertili’Tea Party! – CFAS
-
Jun 15, 2026, 11:37Christopher Robinson: Outcomes in Late Preterm and Term Births with Gestational Diabetes vs Normoglycemia
-
Jun 15, 2026, 11:34Registration Now Open for Fertility 2027 – British Fertility Society
-
Jun 15, 2026, 11:28Ioakeim Sapantzoglou: Excited to Share Our Latest Publication in Archives of Gynecology and Obstetrics!